Verma CS - Search Results

1

De-risking Drug Discovery of Intracellular Targeting Peptides: Screening Strategies to Eliminate False-Positive Hits.

Ng S, Juang YC, Chandramohan A, Kaan HYK, Sadruddin A, Yuen TY, Ferrer-Gago FJ, Lee XC, Liew X, Johannes CW, Brown CJ, Kannan S, Aronica PG, Berglund NA, Verma CS, Liu L, Stoeck A, Sawyer TK, Partridge AW, Lane DP. Ng S, et al. Among authors: verma cs. ACS Med Chem Lett. 2020 May 1;11(10):1993-2001. doi: 10.1021/acsmedchemlett.0c00022. eCollection 2020 Oct 8. ACS Med Chem Lett. 2020. PMID: 33062184 Free PMC article.

2

Substrate specificity of cyclins determined by electrostatics.

Lee HJ, Chua GH, Krishnan A, Lane DP, Verma CS. Lee HJ, et al. Among authors: verma cs. Cell Cycle. 2007 Sep 15;6(18):2219-26. doi: 10.4161/cc.6.18.4706. Epub 2007 Jul 6. Cell Cycle. 2007. PMID: 17890901

3

Modulation of the p53-MDM2 interaction by phosphorylation of Thr18: a computational study.

Lee HJ, Srinivasan D, Coomber D, Lane DP, Verma CS. Lee HJ, et al. Among authors: verma cs. Cell Cycle. 2007 Nov 1;6(21):2604-11. doi: 10.4161/cc.6.21.4923. Epub 2007 Aug 20. Cell Cycle. 2007. PMID: 17957142

4

Updates on p53: modulation of p53 degradation as a therapeutic approach.

Dey A, Verma CS, Lane DP. Dey A, et al. Among authors: verma cs. Br J Cancer. 2008 Jan 15;98(1):4-8. doi: 10.1038/sj.bjc.6604098. Epub 2008 Jan 8. Br J Cancer. 2008. PMID: 18182973 Free PMC article. Review.

5

Molecular simulations of protein dynamics: new windows on mechanisms in biology.

Dodson GG, Lane DP, Verma CS. Dodson GG, et al. Among authors: verma cs. EMBO Rep. 2008 Feb;9(2):144-50. doi: 10.1038/sj.embor.7401160. EMBO Rep. 2008. PMID: 18246106 Free PMC article. Review.

6

The electrostatic surface of MDM2 modulates the specificity of its interaction with phosphorylated and unphosphorylated p53 peptides.

Brown CJ, Srinivasan D, Jun LH, Coomber D, Verma CS, Lane DP. Brown CJ, et al. Among authors: verma cs. Cell Cycle. 2008 Mar 1;7(5):608-10. doi: 10.4161/cc.7.5.5488. Epub 2007 Dec 26. Cell Cycle. 2008. PMID: 18256546

7

Multiple peptide conformations give rise to similar binding affinities: molecular simulations of p53-MDM2.

Dastidar SG, Lane DP, Verma CS. Dastidar SG, et al. Among authors: verma cs. J Am Chem Soc. 2008 Oct 15;130(41):13514-5. doi: 10.1021/ja804289g. Epub 2008 Sep 19. J Am Chem Soc. 2008. PMID: 18800837

8

Dimerization of the core domain of the p53 family: a computational study.

Madhumalar A, Jun LH, Lane DP, Verma CS. Madhumalar A, et al. Among authors: verma cs. Cell Cycle. 2009 Jan 1;8(1):137-48. doi: 10.4161/cc.8.1.7530. Cell Cycle. 2009. PMID: 19106606

9

Crystallization of eIF4E complexed with eIF4GI peptide and glycerol reveals distinct structural differences around the cap-binding site.

Brown CJ, Verma CS, Walkinshaw MD, Lane DP. Brown CJ, et al. Among authors: verma cs. Cell Cycle. 2009 Jun 15;8(12):1905-11. doi: 10.4161/cc.8.12.8742. Epub 2009 Jun 15. Cell Cycle. 2009. PMID: 19440045

10

Design of a novel MDM2 binding peptide based on the p53 family.

Madhumalar A, Lee HJ, Brown CJ, Lane D, Verma C. Madhumalar A, et al. Cell Cycle. 2009 Sep 1;8(17):2828-36. doi: 10.4161/cc.8.17.9516. Epub 2009 Sep 14. Cell Cycle. 2009. PMID: 19713735

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

330 results

Search Page